Revvity, Inc. (RVTY)
NYSE: RVTY · IEX Real-Time Price · USD
102.01
-0.99 (-0.96%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Revvity Revenue

Revvity had revenue of $2.73B in the twelve months ending March 31, 2024, down -9.85% year-over-year. Revenue in the quarter ending March 31, 2024 was $649.92M, a -3.70% decrease year-over-year. In the year 2023, Revvity had annual revenue of $2.75B, a decrease of -16.95%.

Revenue (ttm)
$2.73B
Revenue Growth
-9.85%
P/S Ratio
4.62
Revenue / Employee
$237,011
Employees
11,500
Market Cap
12.59B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.75B-561.25M-16.95%
Jan 1, 20233.31B-515.99M-13.48%
Jan 2, 20223.83B1.16B43.73%
Jan 3, 20212.66B-220.44M-7.64%
Dec 29, 20192.88B105.68M3.80%
Dec 30, 20182.78B521.01M23.08%
Dec 31, 20172.26B141.47M6.69%
Jan 1, 20172.12B10.69M0.51%
Jan 3, 20162.10B34.94M1.69%
Dec 28, 20142.07B-87.71M-4.07%
Dec 29, 20132.16B52.40M2.49%
Dec 30, 20122.11B186.68M9.73%
Jan 1, 20121.92B216.74M12.74%
Jan 2, 20111.70B151.00M9.74%
Jan 3, 20101.55B-108.90M-6.56%
Dec 28, 20081.66B-69.21M-4.00%
Dec 30, 20071.73B251.19M17.00%
Dec 31, 20061.48B3.85M0.26%
Jan 1, 20061.47B44.74M3.13%
Jan 2, 20051.43B84.55M6.29%
Dec 28, 20031.34B-156.45M-10.42%
Dec 29, 20021.50B-24.35M-1.60%
Dec 30, 20011.53B-12.64M-0.82%
Dec 31, 20001.54B487.15M46.36%
Jan 2, 20001.05B196.45M22.99%
Jan 3, 1999854.38M-73.10M-7.88%
Dec 28, 1997927.48M-499.77M-35.02%
Dec 29, 19961.43B7.67M0.54%
Dec 29, 19951.42B87.02M6.53%
Dec 29, 19941.33B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Tenet Healthcare 20.91B
Viatris 15.36B
DaVita 12.34B
Incyte 3.77B
Dr. Reddy's Laboratories 3.35B
Royalty Pharma 2.24B
Neurocrine Biosciences 1.98B
Medpace Holdings 1.96B
Revenue Rankings